ONCOLOGY NURSE PRACTITIONERS AS PRINCIPAL INVESTIGATORS IN EARLY DRUG DEVELOPMENT CLINICAL TRIALS

被引：0
作者：
Jameson, Gayle [1 ]
Pelusi, Jody [2 ]
Rice, David [3 ]
Sharrah, Karen [4 ]
Burns, Kathleen [4 ]
Von Hoff, Daniel [1 ,5 ]
机构：
[1] HonorHealth, Scottsdale, AZ USA
[2] HonorHlth Res Inst, Scottsdale, AZ USA
[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Translat Genom Inst, Phoenix, AZ USA
来源：
ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
442
引用
收藏
页数：2
相关论文
共 50 条
[31]   Site Principal Investigators in Multicenter Clinical Trials Appropriately Recognizing Key Contributors [J].
Mentz, Robert J. ;
Peterson, Eric D. .
CIRCULATION, 2017, 135 (13) :1185-1187
[32]   Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials [J].
Lauren A. Marcath ;
Taylor D. Coe ;
Emily K. Hoylman ;
Bruce G. Redman ;
Daniel L. Hertz .
BMC Cancer, 18
[33]   Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials [J].
Marcath, Lauren A. ;
Coe, Taylor D. ;
Hoylman, Emily K. ;
Redman, Bruce G. ;
Hertz, Daniel L. .
BMC CANCER, 2018, 18
[34]   Characteristics of Chief Investigators of Radiation Oncology Clinical Trials in Australia and New Zealand [J].
Nguyen, H. ;
Montgomery, R. ;
Sundaresan, P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03) :E142-E142
[35]   A Database of Drug Repurposing Clinical Trials in Oncology [J].
Pantziarka, Pan ;
Vandeborne, Liese ;
Bouche, Gauthier .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[36]   Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials [J].
Benjamin, Daniel M. ;
Hey, Spencer P. ;
MacPherson, Amanda ;
Hachem, Yasmina ;
Smith, Kara S. ;
Zhang, Sean X. ;
Wong, Sandy ;
Dolter, Samantha ;
Mandel, David R. ;
Kimmelman, Jonathan .
PLOS ONE, 2022, 17 (02)
[37]   Development and influencing factors of compliance behaviors of investigators in clinical trials [J].
Yu-hong Shen ;
Mao-zhong Li ;
Xin-ping Zhang ;
Zheng-qi Li ;
Li-jun Wang .
Journal of Huazhong University of Science and Technology [Medical Sciences], 2014, 34 :284-288
[38]   Development and Influencing Factors of Compliance Behaviors of Investigators in Clinical Trials [J].
沈玉红 ;
李茂忠 ;
张新平 ;
李正奇 ;
王利军 .
JournalofHuazhongUniversityofScienceandTechnology(MedicalSciences), 2014, 34 (02) :284-288
[39]   Development and influencing factors of compliance behaviors of investigators in clinical trials [J].
Shen, Yu-hong ;
Li, Mao-zhong ;
Zhang, Xin-ping ;
Li, Zheng-qi ;
Wang, Li-jun .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2014, 34 (02) :284-288
[40]   THE ROLE OF THE ONCOLOGY CLINICAL TRIALS NURSE (OCTN) IN RECRUITING MINORITIES AND PATIENTS WITH POOR PERFORMANCE STATUS TO ONCOLOGY CLINICAL TRIALS. [J].
Gansauer, Lucy ;
Alexander, Kathryne ;
Davila, Gitana ;
Steele-Tilton, Angela ;
Thomassie, Amy ;
Castro, Kathleen .
ONCOLOGY NURSING FORUM, 2012, 39 (03) :E196-E197
12345